Curaleaf Keeps Aurora Bid Open, Attacks Organigram Alternative Deal
Image
Stamford -- Curaleaf Holdings says its enhanced premium offer of October 6, 2026 for all outstanding Aurora Cannabis common shares remains open, after Aurora announced an alternative transaction with Organigram Global.
Curaleaf argues its offer delivers better value, a combined business with a stronger capital markets profile, greater certainty and speed to close, and larger anticipated synergies. The offer is made under an Offer to Purchase and Circular dated August 18, 2026, amended on October 6, 2026. Curaleaf has filed a Form F-80 registration statement and a Schedule 14D-1F tender offer statement with the U.S. SEC.